Cargando…

Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease

OBJECTIVE: To date, the extent to which social determinants of health (SDOH) may help identify individuals with atherosclerotic cardiovascular disease (ASCVD) – beyond traditional risk factors – has not been quantified using a cumulative social disadvantage approach. The objective of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Zulqarnain, Valero-Elizondo, Javier, Dudum, Ramzi, Khan, Safi U., Dubey, Prachi, Hyder, Adnan A., Xu, Jiaqiong, Bilal, Usama, Kash, Bita A., Cainzos-Achirica, Miguel, Nasir, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441152/
https://www.ncbi.nlm.nih.gov/pubmed/34553187
http://dx.doi.org/10.1016/j.ajpc.2021.100251
_version_ 1783752818244452352
author Javed, Zulqarnain
Valero-Elizondo, Javier
Dudum, Ramzi
Khan, Safi U.
Dubey, Prachi
Hyder, Adnan A.
Xu, Jiaqiong
Bilal, Usama
Kash, Bita A.
Cainzos-Achirica, Miguel
Nasir, Khurram
author_facet Javed, Zulqarnain
Valero-Elizondo, Javier
Dudum, Ramzi
Khan, Safi U.
Dubey, Prachi
Hyder, Adnan A.
Xu, Jiaqiong
Bilal, Usama
Kash, Bita A.
Cainzos-Achirica, Miguel
Nasir, Khurram
author_sort Javed, Zulqarnain
collection PubMed
description OBJECTIVE: To date, the extent to which social determinants of health (SDOH) may help identify individuals with atherosclerotic cardiovascular disease (ASCVD) – beyond traditional risk factors – has not been quantified using a cumulative social disadvantage approach. The objective of this study was to develop, and validate, a polysocial risk score (PsRS) for prevalent ASCVD in a nationally representative sample of adults in the United States (US). METHODS: We used data from the 2013–2017 National Health Interview Survey. A total of 38 SDOH were identified from the database. Stepwise and criterion-based selection approaches were applied to derive PsRS, after adjusting for traditional risk factors. Logistic regression models were fitted to assign risk scores to individual SDOH, based on relative effect size magnitudes. PsRS was calculated by summing risk scores for individual SDOH, for each participant; and validated using a separate validation cohort. RESULTS: Final sample comprised 164,696 adults. PsRS included 7 SDOH: unemployment, inability to pay medical bills, low income, psychological distress, delayed care due to lack of transport, food insecurity, and less than high school education. PsRS ranged from 0–20 and exhibited excellent calibration and discrimination. Individuals with the highest PsRS (5(th) quintile) had nearly 4-fold higher ASCVD prevalence, relative to those with the lowest risk scores (1(st) quintile). Area under receiver operating curve (AU-ROC) for PsRS with SDOH alone was 0.836. Addition of SDOH to the model with only demographic and clinical risk factors (AU-ROC=0.852) improved overall discriminatory power, with AU-ROC for final PsRS (demographics + clinical + SDOH) = 0.862. CONCLUSIONS: Cumulatively, SDOH may help identify individuals with ASCVD, beyond traditional cardiovascular risk factors. In this study, we provide a unique validated PsRS for ASCVD in a national sample of US adults. Future study should target development of similar scores in diverse populations, and incorporate longitudinal study designs.
format Online
Article
Text
id pubmed-8441152
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84411522021-09-21 Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease Javed, Zulqarnain Valero-Elizondo, Javier Dudum, Ramzi Khan, Safi U. Dubey, Prachi Hyder, Adnan A. Xu, Jiaqiong Bilal, Usama Kash, Bita A. Cainzos-Achirica, Miguel Nasir, Khurram Am J Prev Cardiol Original Research OBJECTIVE: To date, the extent to which social determinants of health (SDOH) may help identify individuals with atherosclerotic cardiovascular disease (ASCVD) – beyond traditional risk factors – has not been quantified using a cumulative social disadvantage approach. The objective of this study was to develop, and validate, a polysocial risk score (PsRS) for prevalent ASCVD in a nationally representative sample of adults in the United States (US). METHODS: We used data from the 2013–2017 National Health Interview Survey. A total of 38 SDOH were identified from the database. Stepwise and criterion-based selection approaches were applied to derive PsRS, after adjusting for traditional risk factors. Logistic regression models were fitted to assign risk scores to individual SDOH, based on relative effect size magnitudes. PsRS was calculated by summing risk scores for individual SDOH, for each participant; and validated using a separate validation cohort. RESULTS: Final sample comprised 164,696 adults. PsRS included 7 SDOH: unemployment, inability to pay medical bills, low income, psychological distress, delayed care due to lack of transport, food insecurity, and less than high school education. PsRS ranged from 0–20 and exhibited excellent calibration and discrimination. Individuals with the highest PsRS (5(th) quintile) had nearly 4-fold higher ASCVD prevalence, relative to those with the lowest risk scores (1(st) quintile). Area under receiver operating curve (AU-ROC) for PsRS with SDOH alone was 0.836. Addition of SDOH to the model with only demographic and clinical risk factors (AU-ROC=0.852) improved overall discriminatory power, with AU-ROC for final PsRS (demographics + clinical + SDOH) = 0.862. CONCLUSIONS: Cumulatively, SDOH may help identify individuals with ASCVD, beyond traditional cardiovascular risk factors. In this study, we provide a unique validated PsRS for ASCVD in a national sample of US adults. Future study should target development of similar scores in diverse populations, and incorporate longitudinal study designs. Elsevier 2021-08-30 /pmc/articles/PMC8441152/ /pubmed/34553187 http://dx.doi.org/10.1016/j.ajpc.2021.100251 Text en © 2021 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Javed, Zulqarnain
Valero-Elizondo, Javier
Dudum, Ramzi
Khan, Safi U.
Dubey, Prachi
Hyder, Adnan A.
Xu, Jiaqiong
Bilal, Usama
Kash, Bita A.
Cainzos-Achirica, Miguel
Nasir, Khurram
Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title_full Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title_fullStr Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title_full_unstemmed Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title_short Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
title_sort development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441152/
https://www.ncbi.nlm.nih.gov/pubmed/34553187
http://dx.doi.org/10.1016/j.ajpc.2021.100251
work_keys_str_mv AT javedzulqarnain developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT valeroelizondojavier developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT dudumramzi developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT khansafiu developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT dubeyprachi developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT hyderadnana developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT xujiaqiong developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT bilalusama developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT kashbitaa developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT cainzosachiricamiguel developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease
AT nasirkhurram developmentandvalidationofapolysocialriskscoreforatheroscleroticcardiovasculardisease